Congenital nystagmus

Gene: MYO5A

Amber List (moderate evidence)

MYO5A (myosin VA)
EnsemblGeneIds (GRCh38): ENSG00000197535
EnsemblGeneIds (GRCh37): ENSG00000197535
OMIM: 160777, Gene2Phenotype
MYO5A is in 6 panels

2 reviews

Ain Roesley (Victorian Clinical Genetics Services)

Green List (high evidence)

Griscelli syndrome (GS) is characterized by partial albinism, neurologic abnormalities and/or immune defects.

It can be categorised into 3 types; type 1: primary dysfunction of central nervous system, type 2: associated with an immune defect and type3: restricted to hypopigmentation without any immunologic or neurologic manifestations

At least 10 families reported with variants in MYO5A, mostly for type 1 but 2,439-bp deletion spanning the entire F-exon has been reported in type 3 patients.
Created: 30 Jan 2022, 11:48 p.m. | Last Modified: 30 Jan 2022, 11:48 p.m.
Panel Version: 0.10812

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Griscelli syndrome, type 1 MIM#214450

Publications

Variants in this GENE are reported as part of current diagnostic practice

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

Partial albinism affecting skin and hair. However, this type of Griscelli syndrome has neurological involvement which results in roving eye movements. Rated Amber due to phenotypic overlap with Hermansky Pudlak syndrome and OCA.
Created: 27 Oct 2021, 7:49 a.m. | Last Modified: 27 Oct 2021, 7:49 a.m.
Panel Version: 0.159

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Griscelli syndrome, type 1, MIM# 214450

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
  • Genomics England PanelApp
  • NHS Genomic Medicine Service
Phenotypes
  • Griscelli syndrome, type 1, MIM# 214450
OMIM
160777
Clinvar variants
Variants in MYO5A
Penetrance
None
Publications
Panels with this gene

History Filter Activity

27 Oct 2021, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: myo5a has been classified as Amber List (Moderate Evidence).

27 Oct 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: MYO5A were changed from Griscelli syndrome, type 1 214450 AR to Griscelli syndrome, type 1, MIM# 214450

27 Oct 2021, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: MYO5A were set to

6 Oct 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Added phenotypes Griscelli syndrome, type 1 214450 AR for gene: MYO5A

6 Oct 2021, Gel status: 2

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: MYO5A was added gene: MYO5A was added to Albinism or congenital nystagmus. Sources: Expert Review Amber,NHS Genomic Medicine Service,Genomics England PanelApp Mode of inheritance for gene: MYO5A was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: MYO5A were set to Griscelli syndrome, type 1 214450 AR